Cognetivity Neurosciences Ltd.
CGNSFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$8959
P/E Ratio—
52W High$0.0019
52W Low$0.0001
Cognetivity Neurosciences Ltd. (CGNSF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CGNSF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-01 | 2022-01 | 2021-01 | 2020-01 | 2019-01 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.05M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $2.18M | $0.02M | $0.01M | $0.01M | $0.00M |
| Gross Profit | ($2.13M) | ($0.02M) | ($0.01M) | ($0.01M) | ($0.00M) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.60M | $0.49M | $0.07M | $0.49M | $0.73M |
| G&A Expenses | $5.04M | $11.52M | $2.09M | $1.61M | $2.46M |
| Total Operating Expenses | $4.16M | $8.96M | $1.28M | $2.61M | $4.21M |
| Operating Income | ($6.29M) | ($13.04M) | ($2.39M) | ($2.60M) | ($4.21M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.02M |
| Interest Expense | $1.03M | $0.06M | $0.06M | $0.06M | $0.00M |
| Income Before Tax | ($7.43M) | ($13.13M) | ($1.93M) | ($2.66M) | ($4.19M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($0.02M) | ($0.02M) |
| Net Income | ($7.43M) | ($13.13M) | ($1.93M) | ($2.65M) | ($4.19M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.09 | $-0.18 | $-0.03 | $-0.06 | $-0.10 |
| Wtd Avg Shares | 85.05M | 73.06M | 58.68M | 45.60M | 40.41M |
| EBITDA | ($6.38M) | ($13.01M) | ($2.39M) | ($2.60M) | ($4.21M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more Cognetivity Neurosciences Ltd. data
About Cognetivity Neurosciences Ltd. (CGNSF) Income Statement
Cognetivity Neurosciences Ltd. (CGNSF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, CGNSF reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -4694.86%), and net income of ($0.01B) — a net profit margin of -16386.31%.
Frequently asked questions
CGNSF · 4 questionsCognetivity Neurosciences Ltd. (CGNSF) reported revenue of $0.00B for 2023, up —% year-over-year.
CGNSF revenueCGNSF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09